theiler
murin
encephalomyel
tmev
model
use
studi
interact
viru
myelin
antineuroantigen
autoimmun
tmev
myelin
interrel
viru
entri
persist
viru
entri
tmev
might
use
peripher
myelin
po
protein
viru
receptor
persist
tmev
seem
requir
myelin
function
protein
structur
myelin
myelin
oligodendrocyt
loss
downregul
myelin
gene
would
lead
demyelin
might
limit
viru
spread
central
nervou
system
unlik
experiment
allerg
encephalomyel
eae
pathogen
role
antimyelin
autoimmun
unclear
tmev
infect
antimyelin
autoantibodi
detect
tmev
infect
among
antigalactocerebrosid
gc
antibodi
shown
myelinotox
molecular
mimicri
tmev
myelinspecif
cell
play
role
initi
progress
demyelin
first
two
three
month
tmev
infect
howev
cellular
autoimmun
sever
myelin
antigen
epitop
spread
detect
late
chronic
stage
use
tmev
model
epitop
spread
autoantibodymedi
remyelin
investig
recombin
tmev
antineuroantigen
natur
antibodi
respect
anim
model
autoimmun
diseas
nervou
system
demyelin
diseas
galactosylceramid
myelin
basic
protein
myelin
proteolipid
protein
multipl
sclerosi
picornavirida
infect
chapter
theiler
murin
encephalomyel
viru
tmev
infect
model
multipl
sclerosi
ms
provid
excel
paradigm
studi
interact
viru
myelin
immun
system
chapter
first
review
associ
tmev
myelin
gene
protein
next
discuss
possibl
role
antimyelin
immun
includ
molecular
mimicri
epitop
spread
pathogenesi
demyelin
final
introduc
two
uniqu
model
system
use
tmev
infect
studi
pathogen
role
molecular
mimicri
ii
explor
potenti
therapeut
agent
remyelinationpromot
autoantibodi
demyelin
diseas
understand
divers
interact
virus
myelin
host
immun
respons
neuroantigen
may
shed
light
etiolog
pathogenesi
ms
tmev
isol
max
theiler
award
nobel
prize
develop
first
effect
vaccin
yellow
fever
tmev
belong
genu
cardioviru
famili
picornavirida
picornavirus
small
nonenvelop
neg
strand
rna
virus
sever
picornavirus
polioviru
coxsackieviru
caus
neurolog
diseas
human
howev
tmev
infect
mice
rat
vivo
caus
demyelin
diseas
mice
thu
tmev
identifi
caus
agent
human
diseas
associ
dermatomyos
vilyuisk
encephalomyel
thu
far
inconclus
theiler
origin
subgroup
includ
daniel
da
bean
ww
strain
produc
biphas
diseas
suscept
mice
inocul
intracerebr
review
first
week
acut
phase
mice
develop
acut
polioencephalomyel
mice
occasion
show
clinic
sign
weight
loss
viru
antigen
express
primarili
neuron
central
nervou
system
cn
subsequ
one
month
post
infect
pi
chronic
phase
mice
show
sign
spastic
paralysi
result
demyelin
within
white
matter
spinal
cord
area
demyelin
associ
perivascular
infiltr
mononuclear
cell
mnc
diseas
progress
without
evid
remiss
either
clinic
patholog
except
mice
infect
ww
strain
tmev
chronic
phase
viral
antigen
express
within
oligodendrocyt
astrocyt
macrophagemicroglia
neuron
review
tmevinduc
demyelin
diseas
one
anim
model
progress
form
ms
although
mani
anim
model
ms
clinic
cours
either
acut
monophas
relapsingremit
rr
anim
model
use
experiment
model
rrm
therefor
tmev
model
uniqu
anim
model
studi
pathogenesi
three
type
ms
primari
progress
pp
secondari
progress
sp
progress
relaps
pr
ms
precis
mechan
demyelin
tmev
infect
clear
two
major
hypothes
direct
viru
infect
myelin
form
cell
ie
oligodendrocyt
ii
immunemedi
mechan
infect
live
tmev
necessari
induc
demyelin
sinc
neither
ultravioletinactiv
tmev
cdna
encod
individu
tmev
capsid
protein
alon
caus
demyelin
virtual
immun
cell
includ
cell
b
cell
macrophag
shown
play
import
role
review
contrast
experiment
allerg
encephalomyel
eae
virusinduc
demyelin
diseas
adopt
transfer
uninfect
immun
cell
tmevinfect
mice
induc
demyelin
recipi
mice
addit
acquir
immun
neither
necessari
suffici
tmev
model
system
tmev
persist
infect
cn
induc
demyelin
major
histocompat
complex
mhc
class
idefici
mice
mhc
class
iidefici
mice
mice
mice
tmev
also
caus
demyelin
spinal
cord
motheaten
mice
lack
protein
tyrosin
phosphatas
earli
five
day
pi
acquir
immun
respons
normal
gener
natur
infect
tmev
spread
mous
mous
oralfec
rout
order
caus
cn
infect
rout
viru
must
get
alimentari
tract
cn
either
hematogen
intraaxon
sinc
strain
subgroup
tmev
could
isol
fece
day
pi
invas
cn
via
neural
rout
persist
infect
intestin
may
one
pathway
origin
suggest
theiler
gard
myelin
multipl
lamellar
membran
sheath
axon
facilit
saltatori
conduct
nerv
impuls
protein
member
immunoglobulin
ig
gene
superfamili
constitut
total
myelin
protein
present
peripher
nervou
system
pn
use
viru
overlay
viru
bind
assay
libbey
et
al
identifi
protein
potenti
receptor
tmev
tabl
suggest
use
protein
schwann
cell
receptor
may
one
mechan
tmev
spread
gastrointestin
tract
cn
vivo
cn
tmev
receptor
neuron
acut
phase
glial
cell
macrophag
chronic
phase
identifi
myelin
basic
protein
mbp
myelin
proteolipid
protein
plp
major
compon
cn
myelin
mani
protein
glycoprotein
present
lesser
extent
bihl
et
al
demonstr
myelin
gene
mutat
could
affect
persist
tmev
susceptibilityresist
chronic
tmev
infect
map
sever
loci
includ
one
tent
locat
telomer
region
chromosom
close
myelin
basic
protein
locu
mbp
locu
determin
mbp
gene
influenc
viral
persist
bihl
et
al
inocul
da
viru
mice
bear
shiver
shi
mutat
delet
gene
wherea
tmevinfect
wildtyp
mice
intermedi
level
viru
persist
day
pi
increas
viral
persist
detect
heterozyg
shi
mice
viru
persist
detect
homozyg
shishi
mice
increas
suscept
heterozyg
shiver
mice
also
seen
x
shi
mice
although
mice
resist
tmev
persist
furthermor
viral
rna
detect
day
da
viru
infect
mice
homozyg
point
mutat
gene
code
plp
previous
plp
rumpshak
rshrsh
mutat
data
avail
control
mice
though
studi
infect
oligodendrocyt
presenc
demyelin
antitmev
immun
respons
test
number
oligodendrocyt
report
normal
even
slightli
increas
uninfect
shiver
rumpshak
mutant
mice
although
myelin
grossli
defici
therefor
result
suggest
tmev
persist
link
myelin
function
alter
exampl
may
chang
viru
abil
replic
traffic
myelin
sheath
although
mbp
gene
mbplink
locu
suggest
influenc
suscept
ms
studi
demonstr
linkag
ms
mbp
gene
gene
encod
myelin
protein
mbp
plp
express
oligodendrocyt
cn
transcript
marker
activ
mainten
reproduct
myelin
yamada
et
al
demonstr
relationship
mbp
plp
mrna
viral
rna
demyelin
within
spinal
cord
tmev
infect
four
week
pi
decreas
level
mbp
plp
mrna
associ
presenc
viral
rna
demyelin
week
pi
howev
extens
demyelin
associ
signific
decreas
mbp
plp
mrna
presenc
viral
rna
result
indic
viral
infect
white
matter
earli
phase
tmev
infect
lead
demyelin
later
cours
diseas
mechan
immunopatholog
process
drive
extens
demyelin
subsequ
report
group
confirm
decreas
plp
mrna
express
infectedbut
also
uninfectedoligodendrocyt
spinal
cord
decreas
mbp
plp
mrna
lesion
indic
either
loss
oligodendrocyt
suppress
myelin
metabol
oligodendrocyt
without
cell
lysi
former
support
find
apoptosi
oligodendrocyt
demyelin
lesion
tmev
infect
latter
possibl
support
fact
virus
known
alter
luxuri
differenti
function
cell
without
disturb
vital
function
ie
abil
surviv
use
electron
microscopi
rodriguez
demonstr
degen
chang
distal
process
oligodendrocyt
tmev
infect
although
dyingback
oligodendrogliopathi
directli
link
suppress
myelin
metabol
similar
ultrastructur
patholog
also
describ
ms
also
polyomavirusinduc
human
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
jc
viru
report
caus
demyelin
lytic
infect
oligodendrocyt
also
via
suppress
myelin
gene
express
review
although
suppress
mbp
plp
mrna
well
demyelin
result
neurolog
function
deficit
might
benefit
host
suppress
viral
replic
cn
discuss
previou
section
persist
viral
infect
seem
requir
either
function
structur
intact
myelin
therefor
suppress
myelin
function
loss
myelin
demyelin
might
serv
protect
role
suppress
viru
persist
tmev
infect
tabl
demyelin
diseas
might
repres
oligodendrocyt
futil
attempt
suppress
viral
replic
ultim
result
potenti
irrevers
myelin
damag
hand
incomplet
suppress
oligodendrocyt
function
might
actual
benefit
viru
sinc
heterozyg
shiver
shi
mutat
result
increas
viral
persist
cn
damag
cn
tissu
liber
cn
antigen
cerebrospin
fluid
csf
compart
mbp
detect
csf
patient
activ
myelin
destruct
caus
ms
process
cn
infarct
rauch
et
al
found
mbp
csf
mice
infect
da
viru
week
pi
also
detect
serum
antimbp
antibodi
tmevinfect
mice
welsh
et
al
also
demonstr
antibodi
respons
myelin
develop
cba
mice
day
bean
viru
infect
reach
peak
day
pi
antimyelin
antibodi
product
prevent
deplet
cell
howev
correl
titer
antimyelin
antibodi
sever
clinic
diseas
use
western
blot
analysi
cash
et
al
studi
specif
ig
secret
b
cell
isol
spinal
cord
sjlj
mice
infect
da
viru
found
antibodi
direct
two
unidentifi
nonvir
protein
molecular
weight
present
white
matter
infect
mice
found
purifi
myelin
rodriguez
et
al
show
like
ms
increas
amount
ig
csf
oligoclon
igg
band
detect
tmevinfect
mice
day
pi
howev
igg
serum
csf
primarili
direct
viru
antigen
rather
normal
myelin
compon
although
rare
exampl
myelin
sheath
posit
igg
found
immunoelectron
microscopi
tmevinfect
mice
hand
roo
et
al
demonstr
heterogen
antitmev
antibodi
csf
less
restrict
oligoclon
igg
band
seen
ms
subacut
scleros
panenceph
sspe
rodriguez
et
al
also
show
complement
deplet
day
pi
result
exacerb
demyelin
day
pi
although
author
suggest
pathogen
role
humor
immun
studi
treatment
hamper
antibodymedi
clearanc
tmev
day
might
earli
assess
effector
mechan
tmev
infect
overt
demyelin
gener
seen
later
direct
pathogen
role
antimbp
antibodi
demyelin
unlik
sinc
antimbp
antibodi
demonstr
myelinotox
either
vivo
vitro
contrast
antibodi
galactocerebrosid
gc
myelin
oligodendrocyt
glycoprotein
mog
whose
adopt
transfer
mice
eae
exacerb
demyelin
function
barbano
dal
canto
demonstr
sera
mice
infect
tmev
two
three
month
injur
myelin
cultur
vitro
studi
suggest
myelinotox
humor
factor
sera
tmevinfect
mice
antimyelin
antibodi
might
indirectli
affect
myelin
antigen
present
class
iirestrict
cell
receptormedi
antigen
uptak
tmev
infect
myelinspecif
surfac
ig
serv
captur
myelin
antigen
surfac
b
cell
b
cell
could
intern
present
myelin
antigen
specif
cell
addit
profession
antigen
present
cell
apc
could
exploit
solubl
antimyelin
antibodi
antigen
captur
fc
receptor
mediat
uptak
myelincontain
immun
complex
would
lead
augment
myelinspecif
cell
respons
also
might
contribut
determin
spread
see
later
section
tmev
infect
suggest
autoimmun
diseas
potenti
benefici
role
antineuroantigen
antibodi
discuss
last
section
chapter
molecular
mimicri
host
protein
microorgan
known
mani
year
crossreact
immun
respons
initi
gener
viru
also
react
myelin
compon
could
lead
demyelin
howev
rauch
et
al
found
antimbp
antibodi
tmev
infect
mice
crossreact
tmev
antigen
lack
cross
reaction
mbp
capsid
protein
also
support
competit
radioimmunoassay
sera
rabbit
subcutan
inject
tmev
capsid
protein
hand
fujinami
et
al
rais
monoclon
antibodi
mab
react
tmev
gc
spleen
cell
balbc
mice
infect
da
viru
intracerebr
gc
major
lipid
compon
myelin
mab
react
viral
capsid
protein
effici
neutral
tmev
vitro
intraneur
inject
mab
sciatic
nerv
induc
schwann
cell
destruct
demyelin
inject
intraven
mice
eae
mab
increas
demyelin
lesion
within
spinal
cord
tenfold
determin
whether
antibodi
similar
mab
exist
viral
infect
mice
infect
tmev
sera
collect
variou
time
infect
antibodi
gc
detect
ten
day
pi
result
suggest
antibodi
type
gener
could
contribut
demyelin
vivo
tmev
infect
interestingli
fujinami
et
al
also
demonstr
anoth
tmevneutr
antibodi
could
react
gc
passiv
administr
mab
result
clearanc
viru
surviv
athym
mice
antibodi
neutral
tmev
yet
myelinotox
tabl
investig
need
clarifi
immunolog
factor
helper
cell
favor
gener
type
antibodi
vivo
presenc
myelinotox
activ
demonstr
csf
sera
demyelin
diseas
gc
mog
identifi
target
molecul
demyelin
antibodi
passiv
transfer
exacerb
initi
demyelin
cn
vivo
antigc
antibodi
also
detect
ms
patient
epitop
spread
play
activ
role
relaps
progress
autoimmun
diseas
first
suggest
eae
lehmann
et
al
initi
immunemedi
tissu
destruct
tissu
debri
taken
macrophag
dendrit
cell
b
cell
present
tissuespecif
cell
spread
specif
immun
respons
one
epitop
anoth
molecul
intramolecular
epitop
spread
exampl
epitop
one
molecul
one
differ
molecul
intermolecular
epitop
spread
exampl
although
tissu
destruct
occur
less
one
week
tmev
infect
epitop
spread
observ
two
three
month
tmev
infect
review
barbano
dal
canto
demonstr
spleen
cell
tmevinfect
mice
injur
myelin
cultur
prolifer
respons
mbp
spinal
cord
homogen
sch
vitro
addit
spleen
cell
produc
diseas
vivo
adopt
transfer
naiv
mice
regardless
whether
vitro
stimul
mbp
sch
similarli
miller
et
al
demonstr
lack
delayedtyp
hypersensit
dth
respons
cell
prolifer
whole
mbp
plp
encephalitogen
peptid
sch
tmevinfect
mice
day
pi
compar
studi
use
eae
model
induc
neuroantigen
also
demonstr
pathogen
role
myelin
specif
cell
earli
chronic
phase
tmev
infect
eae
induc
subcutan
inject
myelin
antigen
emulsifi
complet
freund
adjuv
cfa
emulsif
incomplet
freund
adjuv
ifa
induc
anergi
myelin
antigen
render
resist
subsequ
eae
induct
follow
mbp
sch
emulsifi
ifa
inject
lang
et
al
inject
mice
da
viru
schcfa
eae
induct
found
pretreat
myelin
antigensifa
suppress
eae
induct
tmevinduc
demyelin
day
pi
anoth
protocol
neuroantigensspecif
toler
induct
suppress
eae
also
fail
alter
develop
tmevinduc
demyelin
diseas
day
pi
similarli
use
treatment
regimen
report
suppress
eae
drescher
et
al
demonstr
oral
toler
myelin
alter
tmevinduc
demyelin
day
pi
support
nonautoimmun
mechan
tmevinduc
demyelin
although
tmevinfect
mice
develop
demyelin
diseas
one
month
infect
diseas
progress
continu
myelinspecif
cellular
immun
contribut
neither
initi
progress
demyelin
diseas
least
first
two
three
month
tmev
infect
although
tmevinfect
mice
develop
extens
inflammatori
demyelin
progress
disabl
two
three
month
infect
neurolog
diseas
seem
progress
rest
life
infect
mice
studi
tmevinduc
demyelin
use
mice
infect
tmev
one
two
month
pi
miller
group
examin
role
epitop
spread
initi
antimyelin
autoimmun
respons
sjlj
mice
late
chronic
phase
diseas
two
three
month
bean
strain
tmev
infect
review
previou
section
three
month
pi
tmevinfect
mice
develop
cell
specif
tmev
neuroantigen
howev
miller
group
demonstr
cell
prolifer
tmevinfect
mice
day
day
infect
dth
respons
first
demonstr
day
peripher
tcell
respons
myelin
epitop
develop
progress
diseas
hierarch
order
begin
domin
peptid
onset
demyelin
diseas
progress
respons
variou
lessdomin
encephalitogen
myelin
epitop
develop
although
inconsist
onset
date
antineuroantigen
specif
immun
respons
report
miller
group
overt
antimyelin
immun
respons
seem
detect
around
three
month
tmev
infect
argu
respons
contribut
myelin
damag
time
autoreact
could
initi
part
process
myelin
debri
subsequ
present
myelin
epitop
infiltr
macrophag
resid
perivascular
cellsmicroglia
cn
macrophag
microglia
harvest
cn
earli
chronic
phase
day
tmev
infect
present
viral
peptid
myelin
peptid
howev
day
postinfect
cn
apc
present
viral
myelin
epitop
thl
cell
line
hybridoma
specif
tmev
plp
peptid
absenc
exogen
antigen
vitro
indic
apc
could
endogen
process
present
viral
myelin
antigen
importantli
antibodi
predominantli
inhibit
plpmaslspecif
cell
prolifer
mediat
endogen
antigen
present
cn
apc
tmevinfect
mice
inhibit
compar
inhibit
contrast
predomin
sjlj
mice
rreae
therefor
costimulatori
depend
epitop
spread
differ
tmev
infect
rreae
vivo
costimulatori
blockad
ligand
day
tmev
infect
inhibit
antitmev
immun
respons
increas
viru
persist
acceler
epitop
spread
block
would
intrigu
administ
tmevinfect
mice
earli
chronic
phase
possibl
prime
period
antiplp
respons
treatment
could
inhibit
epitop
spread
without
suppress
antitmev
immun
recent
miller
group
demonstr
treatment
tmevinfect
mice
fusion
protein
consist
plp
mbp
mildli
attenu
diseas
progress
day
pi
result
decreas
inflammatori
cell
infiltr
cn
paradox
splenic
cell
prolif
interferon
ifn
respons
enhanc
mice
dth
respons
downregul
addit
day
pi
mice
show
diseas
sever
compar
control
anim
result
indic
tmev
infect
neither
induc
toler
via
delet
anergi
immun
deviat
thl
respons
contrast
treatment
complet
inhibit
acut
attack
relaps
plpand
mbpinduc
eae
signific
suppress
plpand
mbpspecif
lymphoprolif
respons
administr
also
markedli
amelior
cours
establish
eae
result
suggest
immunolog
paramet
epitop
spread
differ
tmev
infect
eae
anoth
group
also
demonstr
myelin
specificdth
respons
late
chronic
phase
week
pi
earli
chronic
phase
week
pi
indic
autoimmun
respons
play
major
role
initi
demyelin
tmev
infect
correl
clinic
score
strength
dth
respons
myelin
autoantigen
mice
test
week
therefor
author
conclud
antimyelin
autoimmun
might
addit
factor
contribut
lesion
progress
late
chronic
stage
although
autoimmun
myelin
might
repres
epiphenomena
induc
damag
myelin
produc
mechan
unknown
epitop
spread
detect
late
chronic
stage
tmev
infect
addit
viral
induc
tissu
injuri
immunomodul
mous
strain
age
might
contribut
epitop
spread
tmevinfect
sjlj
mice
naiv
sjlj
mice
high
frequenc
specif
cell
increas
age
moreov
age
sjlj
mice
tend
immunolog
abnorm
high
incid
reticulum
cell
sarcoma
paraproteinemia
enlarg
lymph
node
splenomegali
patholog
role
epitop
spread
controversi
even
eae
difficult
verifi
epitop
spread
might
simpli
reflect
releas
autoantigen
secondari
myelin
destruct
may
pathogen
signific
howev
dal
canto
et
al
show
lymph
node
cell
harvest
mice
day
tmev
infect
produc
demyelin
organotyp
cultur
stimul
stimul
whole
mbp
author
suggest
antigen
spread
plp
mbp
might
play
import
role
demyelin
would
intrigu
test
whether
adopt
transfer
plp
peptidestimul
lymphocyt
tmevinfect
mice
could
caus
demyelin
nafv
mice
vivo
possibl
contamin
live
transfer
viru
cultur
effect
whole
plp
mbp
peptid
stimul
lymph
node
cell
also
address
futur
experi
hand
autoimmun
cn
includ
mbpspecif
cell
demonstr
protect
benefici
natur
certain
circumst
therefor
one
rule
possibl
antimyelin
autoimmun
might
play
neuroprotect
role
late
chronic
phase
tmev
infect
time
sever
axon
injuri
loss
demonstr
review
use
tmev
olson
et
al
establish
virusinduc
molecular
mimicri
model
ms
engin
nonpathogen
tmev
aclaibean
encod
infect
tmev
led
rapidonset
paralyt
diseas
within
ten
day
earli
day
pi
inflammatori
demyelin
lesion
detect
spinal
cord
cell
prolifer
dth
respons
detect
spleen
similar
earlyonset
diseas
antiplp
respons
also
observ
mice
infect
tmev
encod
alter
peptid
ligand
apl
amino
acid
substitut
cell
receptor
contact
residu
cell
tmevspecif
cell
mice
transfer
demyelin
diseas
nafv
recipi
induct
toler
infect
prevent
clinic
diseas
author
suggest
virus
induc
plp
specif
cell
lead
earli
onset
demyelin
diseas
inform
avail
patholog
viral
replic
one
week
viru
infect
also
unknown
whether
model
similar
tmev
infect
eae
clinic
histolog
studi
tmev
express
encephalitogen
plp
epitop
well
apl
plp
could
induc
earlyonset
diseas
absenc
stimulu
associ
cfa
contrast
infect
mice
vaccinia
viru
construct
express
entir
code
region
plp
fail
induc
cn
diseas
without
second
challeng
cfa
thu
tmev
might
provid
suffici
signal
induc
autoreact
cell
circumst
importantli
apl
plp
encod
encephalitogen
even
administ
cfa
mice
may
mimic
situat
recent
clinic
trial
ms
administr
apl
mbp
ms
patient
result
induct
mbpspecif
cell
prolifer
exacerb
clinic
sign
contrast
classic
view
antimyelin
immun
respons
play
pathogen
role
cn
demyelin
diseas
autoimmun
myelin
might
play
benefici
role
promot
cn
regener
axon
regener
myelin
regener
remyelin
eae
model
inject
myelin
compon
ifa
amelior
clinic
patholog
demyelin
diseas
therapeut
effect
could
due
suppress
th
cellmedi
autoimmun
product
antimyelin
antibodi
play
direct
role
remyelin
latter
role
agreement
vitro
observ
antibodymedi
oligodendrocyt
stimul
base
initi
observ
traugott
et
al
remyelin
eae
lang
et
al
conduct
similar
experi
mice
infect
da
strain
tmev
three
month
pi
mice
treat
subcutan
inject
mbp
gc
emulsifi
ifa
show
substanti
cn
remyelin
compar
control
treat
anim
follow
paper
howev
demonstr
pretreat
mice
schifa
mbpifa
suppress
clinic
histolog
diseas
tmev
infect
discoveri
certain
autoantibodi
benefici
anim
model
cn
demyelin
suggest
presum
pathogen
role
antibodi
ms
may
need
reevalu
use
tmev
model
rodriguez
colleagu
shown
benefici
role
antineuroantigen
antibodi
due
promot
remyelin
review
spontan
remyelin
impair
sjlj
mice
infect
da
strain
tmev
rodriguez
lennon
observ
passiv
transfer
either
antiserum
purifi
igg
uninfect
syngen
anim
immun
sch
promot
remyelin
oligodendrocyt
cnstype
schwann
cell
pnstype
tmevinfect
mice
astrocyt
common
within
area
remyelin
inflammatori
cell
less
numer
remyelin
area
demyelin
lesion
vivo
autoradiographi
thymidin
demonstr
major
radiolabel
cell
mnc
remyelin
area
contain
gcprolifer
cell
might
immatur
oligodendrocyt
morpholog
howev
subsequ
experi
demonstr
similar
extent
oligodendrocyt
prolifer
also
detect
mice
treat
control
sera
suggest
prolifer
oligodendrocyt
suffici
new
myelin
synthesi
antisch
serum
also
stimul
prolifer
primari
glial
cell
cultur
vitro
effect
treatment
antitmev
antibodi
product
viru
persist
seem
inconclus
mild
increas
antitmev
antibodi
titer
detect
enzymelink
immunosorb
assay
elisa
plaqu
reduct
assay
increas
viral
persist
report
immunohistochemistri
viral
antigen
viru
plaqu
assay
cn
homogen
rodriguez
etal
also
demonstr
treatment
antiserum
purifi
igg
direct
mbp
promot
remyelin
tmev
infect
without
alter
viru
persist
serum
tmevspecif
antibodi
respons
rodriguez
group
also
gener
remyelinationpromot
igm
mab
spleen
cell
mice
inject
sch
show
reactiv
toward
red
blood
cell
antigen
spectrin
sever
protein
antigen
astrocyt
oligodendrocyt
mbp
inject
suppress
cell
infiltr
increas
tmev
persist
cn
level
tmevspecif
igg
similar
control
neither
react
tmev
protein
determin
western
blot
neutral
tmev
vitro
treatment
also
reduc
relaps
rate
demyelin
mening
sjlj
mice
eae
induc
adopt
transfer
cell
result
consist
hypothes
immunomodulatori
function
autoantibodi
although
neither
immun
respons
mbp
extent
remyelin
explor
eae
model
interestingli
howev
increas
rate
oligodendrocyt
remyelin
nonimmun
toxininduc
model
lysolecithininduc
demyelin
igm
mab
also
shown
promot
remyelin
tmev
model
establish
mice
immun
sch
react
mbp
show
intracellular
cell
surfac
stain
oligodendrocyt
antibodi
recogn
differenti
stagespecif
surfac
antigen
oligodendrocyt
know
howev
whether
antibodi
oligodendrocyt
precursor
actual
recogn
cell
vivo
immunoperoxidas
stain
marker
express
presum
glial
progenitor
cell
gin
success
adult
mous
spinal
cord
tmev
infect
even
though
reagent
work
neonat
rat
optic
nerv
system
vitro
sever
antibodi
join
list
immunoglobulin
enhanc
remyelin
theiler
viru
model
list
includ
pool
human
intraven
igg
ivig
polyclon
human
igm
two
human
igm
mab
isol
waldenstrom
macroglobulinemia
neither
ivig
human
igm
bound
human
oligodendrocyt
vitro
two
igm
mab
bound
oligodendrocyt
polyclon
human
igm
neither
polyclon
igg
antisch
igg
ivig
acceler
rate
remyelin
follow
lysolecithininduc
demyelin
sjlj
mice
therefor
author
suggest
igg
igm
antibodi
might
function
enhanc
remyelin
differ
mechan
precis
mechan
remyelin
autoantibodi
unknown
unclear
whether
one
singl
common
mechan
explain
promot
remyelin
remyelinationpromot
sera
igg
igm
antibodi
mani
remyelinationpromot
antibodi
bind
oligodendrocyt
andor
myelin
direct
effect
recogn
cell
hypothes
howev
sinc
remyelinationpromot
autoantibodi
vari
specif
unlik
antibodi
function
directli
common
antigen
receptor
author
also
suggest
opson
myelin
debri
due
igm
antibodi
phagocyt
might
enhanc
clearanc
cellular
debri
damag
area
allow
normal
process
cn
repair
progress
sinc
fc
receptor
phagocyt
gener
bind
fc
portion
igm
igm
like
interact
via
ctl
domain
therebi
allow
antibodyantigen
complex
contain
igm
indirectli
mediat
phagocytosi
although
mechan
fix
promot
uptak
via
complement
receptor
macrophag
role
complement
fc
receptor
test
model
immunomodul
autoantibodi
also
hypothes
howev
data
avail
autoantibodi
treatment
might
influenc
cellular
immun
respons
viru
myelin
antigen
sever
studi
need
perform
clarifi
mechan
remyelin
immunolog
histolog
time
cours
studi
fourweek
antibodi
treatment
period
vivo
traffick
inject
antibodi
addit
know
autoantibodi
stimul
cnstype
remyelin
oligodendrocyt
pnstype
remyelin
schwann
cell
despit
fact
pn
also
express
antigen
includ
mbp
recogn
autoantibodi
note
remyelinationpromot
studi
use
mice
four
six
month
tmev
infect
contrast
tmev
research
group
use
mice
one
two
month
tmev
infect
discuss
earlier
mechan
demyelin
might
differ
two
time
point
interestingli
among
autoantibodi
sever
monoclon
antibodi
shown
characterist
natur
autoantibodi
natur
autoantibodi
usual
igm
whose
physiolog
signific
unknown
present
serum
normal
unimmun
anim
repres
substanti
fraction
total
ig
repertoir
natur
autoantibodi
show
polyreact
toward
multipl
self
nonself
antigen
typic
encod
unmut
germ
line
ig
gene
shown
virus
may
act
polyclon
b
cell
activ
may
releas
antigen
ordinarili
recogn
host
immun
system
may
augment
respons
mani
antigen
mechan
may
explain
induct
autoantibodi
increas
level
natur
autoantibodi
attract
hypothes
presenc
absenc
remyelinationpromot
antibodi
might
alter
diseas
cours
demyelin
diseas
lack
autoantibodi
would
prevent
remyelin
da
virusinduc
progress
diseas
sjlj
mice
may
intrigu
test
whether
autoantibodi
involv
pathogenesi
mice
infect
ww
strain
tmev
develop
relaps
remit
diseas
cours
character
extens
pnsand
cnstype
remyelin
clinic
comparison
level
autoantibodi
patient
rrm
versu
ppand
spm
might
import
patient
ms
clone
possibl
natur
antibodi
establish
oligodendrocytereact
igm
monoclon
antibodi
polyreact
antigenbind
domain
encod
germ
line
gene
addit
matsiota
et
al
found
ms
patient
often
elev
csf
antibodi
level
mani
autoantigen
mbp
suggest
local
expans
b
cell
produc
natur
autoantibodi
whether
antibodi
effect
demyelin
unknown
chapter
review
interact
tmev
myelin
antimyelin
immun
respons
viru
entri
tmev
might
use
peripher
myelin
protein
viru
receptor
requir
myelin
gene
function
myelin
structur
viru
persist
turn
host
downregul
myelin
gene
express
andor
lose
oligodendrocyt
myelin
lead
demyelin
might
also
benefici
host
sinc
prevent
viru
spread
cn
antitmev
humor
immun
respons
help
viru
clearanc
antivir
antibodi
might
crossreact
host
myelin
molecul
includ
gc
lead
exacerb
demyelin
earli
chronic
phase
cellular
immun
respons
tmev
myelin
detect
howev
epitop
spread
seem
develop
late
chronic
phase
cell
respons
encephalitogen
epitop
plp
mbp
mog
detect
impair
remyelin
could
also
contribut
diseas
progress
presenc
absenc
remyelinationpromot
antibodi
might
import
diseas
remiss
interact
viru
myelin
autoimmun
respons
singl
mechan
may
sole
respons
demyelin
howev
interact
potenti
contribut
progress
demyelin
diseas
varieti
differ
pathogen
mechan
oligodendrocyt
infect
apoptosi
axon
injuri
antitmev
immun
respons
seem
act
parallel
sequenc
caus
myelin
destruct
figur
